Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103.
暂无分享，去创建一个
B. Barlogie | J. Shaughnessy | T. Garg | F. van Rhee | K. Stone | J. Szymonifka | H. G. Prentice | S. Szmania | A. Moreno-Bost | Antje Hoerring | H. Prentice